Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
Breast Cancer Research and Treatment
|
June 9, 2000
Cellular responses of mammary carcinomas to aromatase inhibitors: effects of vorozole
K Christov, A Shilkaitis, A Green, et al.
Cancer Research
|
January 15, 1991
Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone
T A Ratko, C J Detrisac, R G Mehta, et al.
Cancer Research
|
October 19, 2001
Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models
K P Bhat, D Lantvit, K Christov, et al.
Anticancer Research
|
September 1, 1994
A correlative approach for the identification of antimutagens that demonstrate chemopreventive activity
L A Shamon, C Chen, R G Mehta, et al.
Cancer
|
July 15, 1984
Retinoic-acid-binding protein in normal and neoplastic human esophagus
K Dowlatshahi, R G Mehta, B Levin, et al.
Cancer Research
|
February 1, 1982
Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy
D L McCormick, R G Mehta, C A Thompson, et al.
Journal of the National Cancer Institute
|
February 5, 1997
Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5
R G Mehta, R M Moriarty, R R Mehta, et al.
Anticancer Research
|
August 11, 2001
Discovery of novel inducers of cellular differentiation using HL-60 promyelocytic cells
E Mata-Greenwood, A Ito, H Westenburg, et al.
Anticancer Research
|
May 1, 1994
Structure-activity relationships of brassinin in preventing the development of carcinogen-induced mammary lesions in organ culture
R G Mehta, J Liu, A Constantinou, et al.
Carcinogenesis
|
September 1, 1989
Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor
R C Moon, J F Pritchard, R G Mehta, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
Breast Cancer Research and Treatment
|
June 9, 2000
Cellular responses of mammary carcinomas to aromatase inhibitors: effects of vorozole
K Christov, A Shilkaitis, A Green, et al.
Cancer Research
|
January 15, 1991
Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone
T A Ratko, C J Detrisac, R G Mehta, et al.
Cancer Research
|
October 19, 2001
Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models
K P Bhat, D Lantvit, K Christov, et al.
Anticancer Research
|
September 1, 1994
A correlative approach for the identification of antimutagens that demonstrate chemopreventive activity
L A Shamon, C Chen, R G Mehta, et al.
Cancer
|
July 15, 1984
Retinoic-acid-binding protein in normal and neoplastic human esophagus
K Dowlatshahi, R G Mehta, B Levin, et al.
Cancer Research
|
February 1, 1982
Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy
D L McCormick, R G Mehta, C A Thompson, et al.
Journal of the National Cancer Institute
|
February 5, 1997
Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5
R G Mehta, R M Moriarty, R R Mehta, et al.
Anticancer Research
|
August 11, 2001
Discovery of novel inducers of cellular differentiation using HL-60 promyelocytic cells
E Mata-Greenwood, A Ito, H Westenburg, et al.
Anticancer Research
|
May 1, 1994
Structure-activity relationships of brassinin in preventing the development of carcinogen-induced mammary lesions in organ culture
R G Mehta, J Liu, A Constantinou, et al.
Carcinogenesis
|
September 1, 1989
Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor
R C Moon, J F Pritchard, R G Mehta, et al.
Page
of 7